ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,055Medicare Part D Prescriptions Filled, Including Refills

Rank: 185 out of 939

$693K Total Retail Price of All Prescriptions

Rank: 134 out of 939

458 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 6,840 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 411 279 1 4
LISINOPRIL 366 254 2 3
OMEPRAZOLE 307 179 3 5
SIMVASTATIN 300 207 4 2
AMLODIPINE BESYLATE 231 171 5 6
FUROSEMIDE 230 137 6 7
CITALOPRAM HBR 225 156 7 15
POLYETHYLENE GLYCOL 3350 218 102 8 57
GABAPENTIN 216 70 9 11
QUETIAPINE FUMARATE 207 70 10 69
PRAVASTATIN SODIUM 207 175 10 13
CLOZAPINE 199 37 12 203
HYDROCODONE-ACETAMINOPHEN 198 104 S3 13 1
POTASSIUM CHLORIDE 187 106 14 9
MELOXICAM 170 109 15 14
WARFARIN SODIUM 167 97 16 17
TAMSULOSIN HCL 166 100 17 27
HALOPERIDOL 151 53 18 169
METOPROLOL SUCCINATE 146 90 19 21
ZOLPIDEM TARTRATE 140 101 20 20
METFORMIN HCL 132 87 21 8
METOPROLOL TARTRATE 126 80 22 10
HYDROCHLOROTHIAZIDE 124 115 23 12
GLIMEPIRIDE 121 84 24 37
NEXIUM 121 67 24 18
METFORMIN HCL ER 107 52 26 76
ATENOLOL 106 77 27 19
RANITIDINE HCL 103 76 28 35
TRAMADOL HCL 103 38 28 16
TIZANIDINE HCL 99 47 30 81
LITHIUM CARBONATE 98 17 31 234
DIVALPROEX SODIUM 97 34 32 95
IBUPROFEN 96 45 33 112
PHENYTOIN SODIUM EXTENDED 95 47 34 99
LACTULOSE 93 38 35 195
LOSARTAN POTASSIUM 85 66 36 29
ALENDRONATE SODIUM 81 45 37 40
CARVEDILOL 80 51 38 25
SERTRALINE HCL 80 41 38 24
ROPINIROLE HCL 77 69 40 78
PAROXETINE HCL 76 50 41 70
NAMENDA 73 47 42 49
OLANZAPINE ODT 72 39 43 328
DIVALPROEX SODIUM ER 71 0 44 146
LEVOFLOXACIN 70 41 45 86
ATORVASTATIN CALCIUM 67 42 46 22
DICLOFENAC SODIUM 65 32 47 93
OXCARBAZEPINE 64 23 48 227
FLUOXETINE HCL 63 31 49 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 40 50 64
TRAZODONE HCL 60 48 51 26
CLOPIDOGREL 59 44 52 28
SEROQUEL 59 11 52 139
TOPIRAMATE 59 0 52 154
CEPHALEXIN 58 19 55 77
TRIAMTERENE-HCTZ 57 50 56 33
CEFDINIR 57 44 56 142
ESCITALOPRAM OXALATE 56 23 58 61
CARBAMAZEPINE 56 47 58 189
DONEPEZIL HCL 54 47 60 30
VENLAFAXINE HCL ER 53 23 61 121
FINASTERIDE 52 30 62 131
DOXYCYCLINE HYCLATE 51 22 63 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.